Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using the VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in Japan

Mayu Nagura-Ikeda, Kazuo Imai, Katsumi Kubota, Sakiko Noguchi, Yutaro Kitagawa, Masaru Matsuoka, Sakiko Tabata, Kazuyasu Miyoshi, Toshimitsu Ito, Kaku Tamura, Takuya Maeda
doi: https://doi.org/10.1101/2020.08.02.20166256

Data Availability

The raw data used in this study is available from the corresponding author upon reasonable request.

Back to top
Posted August 04, 2020.
Download PDF
Data/Code
Email
Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using the VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in Japan
Mayu Nagura-Ikeda, Kazuo Imai, Katsumi Kubota, Sakiko Noguchi, Yutaro Kitagawa, Masaru Matsuoka, Sakiko Tabata, Kazuyasu Miyoshi, Toshimitsu Ito, Kaku Tamura, Takuya Maeda
medRxiv 2020.08.02.20166256; doi: https://doi.org/10.1101/2020.08.02.20166256
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area